The research direction and strategy of the DIOGENE Biomedical Science Laboratory is the "Human Network".

Independent operation of R&D team
The DIOGENE Biomedical Science Laboratory, operated by its own R&D team for each research subject, has launched the cancer genetic testing product "TumorClean™" through constant R&D, and has focused on improving and improving the quality of "BraClean™", a genetic breast cancer genetic mutation analysis reagent. We will also strive to acquire more diverse customers by developing and securing more disease diagnosis reagents.
Diverse service program
Improve and diversify our service programs through mutual collaboration with domestic and foreign hospitals, genomic analysis companies, university research institutes, and government-run laboratories.
BIO network
A close network with overseas research institutions, bio-companies, and scholars to expand services to customers in East Asian countries and overseas countries with relatively similar genetic backgrounds to Koreans.